Respiratory Gating Market

Starting at US$ 5000

Buy Now
Infographics Companies
Market Size (2026)
USD 2.66 Bn
Forecast (2036)
USD 5.16 Bn
CAGR (2026 to 2036)
7.5%

Respiratory Gating Market Size, Market Forecast and Outlook By FMI

Summary of the Respiratory Gating Market

  • Demand and Growth Drivers
    • Growth in cancer diagnosis volumes and radiation therapy utilization is likely to sustain demand for respiratory gating systems that compensate for breathing motion during thoracic and abdominal imaging and treatment.
    • Adoption of advanced imaging modalities including 4D CT, PET/CT, and MRI-guided radiation therapy is expected to increase procurement of integrated respiratory gating solutions during the forecast period.
    • Clinical evidence supporting improved treatment accuracy and reduced toxicity with gated radiation delivery is likely to accelerate hospital procurement through 2036.
  • Product and Segment View
    • Systems with In-built Gating (CT, MRI, PET, SPECT and Radiotherapy) is likely to account for 54.1% of the product segment, reflecting sustained procurement across primary end-use categories.
    • CT is likely to account for 31.4% of the modality segment, reflecting sustained procurement across primary end-use categories.
    • CT is likely to account for 31.4% of the modality segment, reflecting sustained procurement across primary end-use categories.
  • Geography and Competitive Outlook
    • China is likely to remain a key market at 13.0%, supported by rapid oncology infrastructure expansion.
    • UK is likely to sustain growth at 8.8%, driven by NHS cancer treatment investment.
    • Companies that combine product breadth with end-use customer access and regional distribution are likely to strengthen competitive positioning during the forecast period.
  • Analyst Opinion
    • Sabyasachi Ghosh, Principal Consultant at FMI says, 'The respiratory gating market is evolving from standalone motion management toward fully integrated imaging and treatment solutions. Companies that can deliver integrated gating integration across CT, MRI, and radiation therapy platforms with demonstrated clinical outcome improvement are positioned to lead procurement decisions in comprehensive cancer centers.'
    • The respiratory gating market is evolving from add-on motion management toward integrated imaging and treatment solutions.
    • Adoption is increasing due to cancer treatment volume growth and clinical demand for improved treatment precision.
    • Demand is further supported by MRI-guided radiation therapy adoption requiring real-time respiratory motion management.
    • Companies with multi-platform integration capability and demonstrated clinical outcome improvement are likely to lead procurement.
Respiratory Gating Market Value Analysis
Respiratory Gating Market Value Analysis

Key Takeaways

  • The respiratory gating market was valued at USD 2.33 billion in 2025.
  • By 2036, the Respiratory Gating Market is expected to be worth USD 5.16 billion.
  • From 2026 to 2036, the market is projected to expand at a CAGR of 7.5%.
  • The market is projected to create an incremental opportunity of USD 2.66 billion between 2026 and 2036.
  • In 2026, systems with in-built gating (CT, MRI, PET, SPECT, and radiotherapy) are expected to account for 54.1% of the product segment, driven by expanding clinical adoption of motion-compensated imaging and radiation therapy systems that improve diagnostic accuracy and treatment precision for thoracic and abdominal targets.
  • China (13.0%) and the UK (8.8%) are two of the fastest-growing markets in the world.

Respiratory Gating Market Definition

The respiratory gating market includes respiratory motion management systems used in diagnostic imaging and radiation therapy to compensate for breathing motion during thoracic and abdominal scanning and treatment, covering integrated and standalone gating solutions across CT, MRI, PET, SPECT, and linear accelerator platforms.

Respiratory Gating Market Inclusions

Market scope encompasses all commercially traded respiratory gating products categorized by product type (systems with in-built gating, standalone gating systems, accessories), modality (CT, MRI, PET, SPECT, radiotherapy), technology (respiratory gating, optical surface monitoring, spirometry-based, electromagnetic tracking), end user (hospitals, cancer centers, diagnostic imaging centers), and distribution channel (direct sales, medical equipment distributors). The range of revenue sizes is from 2026 to 2036.

Respiratory Gating Market Exclusions

The scope does not include cardiac gating systems for ECG-synchronized imaging, general patient positioning systems without respiratory motion management, or breath-hold devices not integrated with imaging or treatment equipment.

Respiratory Gating Market Research Methodology

  • Primary Research: FMI analysts conducted interviews with manufacturers, end-use procurement teams, and distribution partners across key markets.
  • Desk Research: Combined data from industry associations, regulatory filings, trade publications, and manufacturer disclosures.
  • Market sizing and forecasting: Bottom-up aggregation across product types, end-use applications, and regional adoption curves, validated against industry benchmarks.
  • Data validation: Cross-checked every quarter against production data, trade statistics, and manufacturer-reported figures.

Why is the Respiratory Gating Market Growing?

  • Cancer diagnosis growth and radiation therapy utilization are creating sustained demand for respiratory gating systems that improve imaging accuracy and treatment precision for motion-affected anatomical sites.
  • Adoption of advanced imaging modalities with integrated gating capability is increasing procurement of respiratory motion management solutions.
  • China (13.0%) and the UK (8.8%) lead growth, reflecting rapid oncology infrastructure expansion and clinical adoption of motion-compensated treatment technologies.

The respiratory gating market is expanding at 7.5% CAGR, reflecting the convergence of cancer treatment growth, imaging technology advancement, and clinical demand for motion-compensated therapy. Systems with in-built gating (CT, MRI, PET, SPECT and radiotherapy) account for 54.1% of the product segment, reflecting the market shift toward integrated motion management rather than standalone add-on devices.

CT accounts for 31.4% of the modality segment, representing the most widely used imaging platform for respiratory-gated scanning. Respiratory gating technology accounts for 38.9% of the technology segment, with optical surface monitoring at 29.7% as a complementary approach. Hospitals account for 47.6% of the end-user segment.

Clinical evidence demonstrates that respiratory gating reduces motion artifacts in diagnostic imaging and improves target conformity in radiation therapy, leading to better tumor control and reduced normal tissue toxicity. These clinical benefits create procurement justification for hospitals investing in comprehensive motion management solutions.

Market Segmentation Analysis

  • Systems with In-built Gating (CT, MRI, PET, SPECT and Radiotherapy) accounts for 54.1% of the product segment, reflecting consistent demand across primary commercial applications.
  • CT accounts for 31.4% of the modality segment, reflecting consistent demand across primary commercial applications.
  • CT accounts for 31.4% of the modality segment, reflecting consistent demand across primary commercial applications.

The respiratory gating market is segmented by product, modality, modality, gating type, technology, end user. Each segmentation dimension reflects distinct procurement patterns and end-use requirements.

Insights into the Systems with In-built Gating (CT, MRI, PET, SPECT and Radiotherapy) Product Segment

Respiratory Gating Market Analysis By Product
Respiratory Gating Market Analysis By Product

In 2026, systems with in-built gating (ct, mri, pet, spect and radiotherapy) is expected to account for 54.1% of the product segment. Demand reflects procurement preferences where performance consistency and specification compliance are critical selection criteria.

Competitive positioning within this segment depends on production capability, quality certification, and the ability to meet evolving end-use requirements. Suppliers with established relationships and proven track records are likely to maintain share.

Insights into the CT Modality Segment

Respiratory Gating Market Analysis By Modality
Respiratory Gating Market Analysis By Modality

In 2026, ct is expected to account for 31.4% of the modality segment. Demand reflects procurement preferences where performance consistency and specification compliance are critical selection criteria.

Competitive positioning within this segment depends on production capability, quality certification, and the ability to meet evolving end-use requirements. Suppliers with established relationships and proven track records are likely to maintain share.

Respiratory Gating Market Drivers, Restraints, and Opportunities

  • Cancer treatment volume growth and clinical demand for motion-compensated imaging and radiation therapy are creating sustained demand for respiratory gating systems.
  • High integration costs and technical complexity limit adoption to larger cancer centers with advanced imaging and radiation therapy infrastructure.
  • Clinical evidence supporting improved diagnostic accuracy and treatment outcomes with respiratory gating is strengthening hospital procurement business cases.

The respiratory gating market reflects oncology treatment expansion, imaging technology advancement, and clinical evidence demonstrating motion management value.

Cancer Treatment Volume Growth

Increasing cancer diagnosis rates and radiation therapy utilization create sustained demand for respiratory gating across diagnostic imaging and treatment delivery. Each new linear accelerator or advanced imaging system installation represents a potential gating system procurement opportunity.

Integration Cost and Technical Complexity

Respiratory gating systems require integration with existing imaging and treatment equipment, adding capital and workflow complexity. This concentrates adoption in academic and large community cancer centers with the infrastructure and expertise to support implementation.

MRI-Guided Radiation Therapy Growth

Adoption of MRI-guided linear accelerators creates demand for real-time respiratory motion management that leverages continuous soft-tissue imaging. This emerging modality represents the highest-specification application of respiratory gating technology.

Analysis of Respiratory Gating Market By Key Countries

Top Country Growth Comparison Respiratory Gating Market Cagr (2026 2036)
Top Country Growth Comparison Respiratory Gating Market Cagr (2026 2036)
Country CAGR
China 13.0%
UK 8.8%
India 8.5%
France 7.6%
USA 7.1%
Germany 6.1%
  • China leads with 13.0%, supported by rapid oncology infrastructure expansion.
  • UK at 8.8%, reflecting NHS cancer treatment investment.
  • India at 8.5%, reflecting expanding cancer treatment infrastructure.

The global respiratory gating market is expected to grow at a rate of 7.5% per year from 2026 to 2036. The study covers more than 30 countries, and the main markets are listed below.

Respiratory Gating Market Cagr Analysis By Country
Respiratory Gating Market Cagr Analysis By Country

Demand Outlook for Respiratory Gating Market in China

China is expected to grow at 13.0% through 2036, reflecting rapid oncology infrastructure expansion, hospital construction with advanced treatment equipment, and growing radiation therapy utilization.

  • Oncology infrastructure expansion creates rapid growth.
  • Hospital construction includes advanced treatment systems.
  • Growing RT utilization sustains equipment demand.

Future Outlook for Respiratory Gating Market in UK

UK is expected to grow at 8.8% through 2036, reflecting NHS cancer treatment investment, adoption of advanced radiation therapy, and clinical research in motion-compensated treatment.

  • NHS cancer investment accelerates treatment technology.
  • Advanced RT adoption drives gating procurement.
  • Clinical research supports motion management.

Opportunity Analysis of Respiratory Gating Market in India

India is expected to grow at 8.5% through 2036, reflecting expanding cancer treatment infrastructure, hospital investment in radiation therapy equipment, and growing clinical adoption of advanced treatment technologies.

  • Cancer treatment expansion creates infrastructure demand.
  • Hospital investment accelerates technology adoption.
  • Growing RT volumes sustain procurement growth.

In-depth Analysis of Respiratory Gating Market in France

France is expected to grow at 7.6% through 2036, reflecting established oncology treatment programs, radiation therapy infrastructure modernization, and clinical research activity.

  • Established oncology programs sustain baseline demand.
  • RT modernization drives equipment procurement.
  • Clinical research supports gating technology adoption.

Sales Analysis of Respiratory Gating Market in USA

Respiratory Gating Market Country Value Analysis
Respiratory Gating Market Country Value Analysis

USA is expected to grow at 7.1% through 2036, reflecting large oncology treatment volume, advanced radiation therapy infrastructure, and clinical research leadership in motion management technology.

  • Large oncology volume sustains gating system demand.
  • Advanced RT infrastructure supports integrated solutions.
  • Clinical research leadership drives technology adoption.

Growth Analysis of Respiratory Gating Market in Germany

Respiratory Gating Market Europe Country Market Share Analysis, 2026 & 2036
Respiratory Gating Market Europe Country Market Share Analysis, 2026 & 2036

Germany is expected to grow at 6.1% through 2036, reflecting advanced radiation therapy and imaging infrastructure, strong clinical research, and hospital investment in treatment precision technology.

  • Advanced RT infrastructure sustains consistent demand.
  • Clinical research supports motion management evidence.
  • Hospital investment drives precision treatment adoption.

Competitive Landscape and Strategic Positioning

Respiratory Gating Market Analysis By Company
Respiratory Gating Market Analysis By Company
  • Siemens Healthineers and GE HealthCare lead through broad product portfolios and established end-use customer relationships.
  • Mid-tier producers compete through regional specialization and targeted product development for specific application segments.
  • New entrants are focusing on technology-differentiated products and specialized applications to establish market presence.

Siemens Healthineers holds a strong position through technology leadership and established customer relationships. GE HealthCare competes through complementary capabilities and regional strength.

Philips Healthcare and Canon Medical Systems maintain positions through specialized offerings and technical capabilities.

Barriers include established relationships, regulatory requirements, technology expertise, and manufacturing scale. Strategic priorities include technology advancement, regulatory compliance, and geographic expansion.

Key Companies in the Respiratory Gating Market

Key global companies leading the respiratory gating market include:

  • Siemens Healthineers, GE HealthCare, Philips Healthcare hold leading positions through technology leadership and established customer relationships.
  • Canon Medical Systems, Fujifilm have established positions through specialized offerings and regional expertise.
  • C-RAD AB, Elekta AB, Varian (Siemens Healthineers) represent emerging participants with growth potential through technology differentiation.

Competitive Benchmarking: Respiratory Gating Market

Company Technology Range Imaging Integration Clinical Evidence Geographic Reach
Siemens Healthineers High High High Global
GE HealthCare High Medium High Global
Philips Healthcare Medium Medium Medium Global
Canon Medical Systems Medium Moderate Medium Regional
Fujifilm Moderate Moderate Moderate Regional
Brainlab AG Moderate Low Moderate Regional
C-RAD AB Low Low Low Niche
Elekta AB Low Low Low Niche
Varian (Siemens Healthineers) Low Low Low Niche
Accuray Incorporated Low Low Low Niche

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Respiratory Gating Market

  • In 2025, Siemens Healthineers launched an updated respiratory gating module for its CT and PET/CT platforms with improved motion tracking accuracy and automated workflow integration.
  • In 2025, Vision RT Ltd. expanded its optical surface monitoring system compatibility to additional linear accelerator platforms for real-time respiratory motion management.

Key Players in the Respiratory Gating Market

Major Global Players

  • Siemens Healthineers
  • GE HealthCare
  • Philips Healthcare
  • Canon Medical Systems
  • Fujifilm
  • Brainlab AG
  • Vision RT Ltd.

Emerging Players/Startups

  • C-RAD AB
  • Elekta AB
  • Varian (Siemens Healthineers)
  • Accuray Incorporated
  • ViewRay Technologies

Report Scope and Coverage

Respiratory Gating Market Breakdown By Product, Modality, And Region
Respiratory Gating Market Breakdown By Product, Modality, And Region
Quantitative Units USD 2.50 Billion to USD 5.16 Billion, at a CAGR of 7.5%
Market Definition The respiratory gating market encompasses respiratory gating systems and motion management solutions integrated with CT, MRI, PET, SPECT, and radiation therapy platforms for motion-compensated diagnostic imaging and cancer treatment.
Regions Covered North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered USA, Germany, France, UK, China, India, 30 plus countries
Key Companies Profiled Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, Fujifilm, Brainlab AG, Vision RT Ltd., Anzai Medical, Co., Ltd, Schiller AG, C-RAD, Elekta, Accuray Incorporated, MIM Software Inc., Raditec Medical AG, Ivy Biomedical Systems, Inc, SDX (DYN’R Medical Systems), Cardiac Imaging, Inc.
Forecast Period 2026 to 2036
Approach Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Segmentation

Respiratory Gating Market Segmented by Product:

  • Systems with In-built Gating (CT, MRI, PET, SPECT and Radiotherapy)
  • Standalone Gating Systems (CT, MRI, PET, SPECT and Radiotherapy)
  • Software (Cardiac Gating Software and Respiratory Gating Software)

Respiratory Gating Market Segmented by Modality:

  • CT
  • MRI
  • PET
  • SPECT
  • Radiotherapy

Respiratory Gating Market Segmented by Modality:

  • CT
  • MRI
  • PET
  • SPECT
  • Radiotherapy

Respiratory Gating Market Segmented by Gating Type:

  • Respiratory Gating
  • Cardiac Gating
  • Multimodality Gating

Respiratory Gating Market Segmented by Technology:

  • Optical Surface Monitoring
  • ECG-triggering
  • Pressure Sensor Based
  • Electromagnetic
  • Among Others

Respiratory Gating Market Segmented by End User:

  • Hospitals
  • Specialty Clinics
  • Imaging and Diagnostic Centers
  • Cancer Treatment and Radiotherapy Centers
  • Academic & Research Institutions

Respiratory Gating Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • USA Food and Drug Administration. (2024). FDA Guidance on Respiratory Motion Management Devices for Radiation Therapy. FDA.
  • World Health Organization. (2024). WHO Global Cancer Report: Treatment Technology Assessment. WHO.
  • American Society for Radiation Oncology. (2025). ASTRO Clinical Guidelines on Motion Management in Radiation Therapy. ASTRO.
  • European Society for Radiotherapy and Oncology. (2024). ESTRO Consensus Guidelines on Respiratory Gating. ESTRO.
  • International Atomic Energy Agency. (2025). IAEA Technical Report on Quality Assurance for Motion-Managed Radiation Therapy. IAEA.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

  • Estimating the size of the market and revenue from 2026 to 2036.
  • Segmentation analysis across all product, application, and end-use categories.
  • Regional insights covering more than 30 markets worldwide.
  • Technology and material analysis relevant to market applications.
  • Competitive landscape assessment including company benchmarking.
  • Identification of investment opportunities across high-growth segments and regions.
  • Supply chain analysis and distribution channel assessment.
  • Data delivery in PDF and Excel formats.

Frequently Asked Questions

What is the global market demand for Respiratory Gating Market in 2026?

In 2026, the global respiratory gating market is expected to be worth USD 2.50 billion.

How big will the Respiratory Gating Market be in 2036?

By 2036, the respiratory gating market is expected to be worth USD 5.16 billion.

How much is demand for Respiratory Gating Market expected to grow between 2026 and 2036?

Between 2026 and 2036, demand for the respiratory gating market is expected to grow at a CAGR of 7.5%.

Which Product segment is likely to lead globally in 2026?

Systems with In-built Gating (CT, MRI, PET, SPECT and Radiotherapy) is expected to account for 54.1% of the product segment in 2026, reflecting strong end-use demand.

What is causing demand to rise in China?

China is expected to grow at 13.0% through 2036, reflecting rapid oncology infrastructure expansion, hospital construction with advanced treatment equipment, and growing radiation therapy utilization.

What is causing demand to rise in UK?

UK is expected to grow at 8.8% through 2036, reflecting NHS cancer treatment investment, adoption of advanced radiation therapy, and clinical research in motion-compensated treatment.

What does this report mean by 'Respiratory Gating Market definition'?

The respiratory gating market encompasses respiratory gating systems and motion management solutions integrated with CT, MRI, PET, SPECT, and radiation therapy platforms for motion-compensated diagnostic imaging and cancer treatment.

How does FMI make the Respiratory Gating Market forecast and validate it?

Forecasting models use a hybrid bottom-up and top-down approach, starting with verified transaction data and validating against industry production statistics and manufacturer disclosures.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Respiratory Gating Market